Few companies in the global consumer staples sector can claim a dividend increase streak spanning nearly seven decades, but this household and personal care products giant has done exactly that — raising its payout for more than 50 consecutive years and paying dividends without interruption for 135 years. With a beta of just 0.40, its monthly price movements show remarkably little correlation to broader equity market swings, making it one of the most genuinely defensive dividend holdings available to income investors. Its 3-year dividend CAGR of 5% sits in the middle quintile of all dividend stocks, reflecting a company that prioritizes sustainable, measured income growth over yield chasing — exactly the profile that anchors a quality dividend portfolio over the long run. Operating across laundry and cleaning products, personal care, baby care, oral hygiene, and grooming categories, this business reaches consumers in approximately 180 countries, generating revenues across a portfolio of category-leading brands that consumers purchase repeatedly regardless of economic conditions.
The near-term backdrop is not without complexity. North America, the company’s largest and most profitable market, experienced organic sales softness in the most recent quarter, compounded by an unusually strong prior-year comparison period. Gross margin came under modest pressure, and the company has initiated restructuring efforts under a new chief executive who is undertaking a broader reinvention of the business. Inflationary pressures on food, energy, and health care have constrained consumer discretionary spending, which can reduce trading-up behavior even in the staples categories where this company competes. These are real headwinds, but they appear transitional rather than structural, given that the company’s brands retain global market leadership and its innovation pipeline is actively building toward a second-half recovery.
The Best Dividend Stocks Portfolio has increased its position in this holding because its extraordinary dividend consistency, ultra-low market volatility, and meaningful analyst price target upside align precisely with the portfolio’s mandate to compound quality income with minimal downside risk.
